Fexofenadine Hydrochloride Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global fexofenadine hydrochloride market is expected to grow at a significant CAGR during the forecast period (2021-2027). Fexofenadine is an antihistamine pharmaceutical medicine used to treat allergy symptoms such as hay fever and urticaria. It is available under the trade names Allegra and others. Fexofenadine is a selective peripheral H1 blocker that can be used therapeutically. It is classed as a second-generation antihistamine as it is less likely than first-generation antihistamines to cross the blood–brain barrier and cause drowsiness.
To Request a Sample of our Report on Fexofenadine
Hydrochloride Market:
https://www.omrglobal.com/request-sample/fexofenadine-hydrochloride-market
The key companies operating in
the industry are highly inclined towards the adoption of different growth
strategies including partnerships and collaborations, mergers and acquisitions,
geographical expansion, and new product launches, to remain competitive in the
marketplace. For instance, in July 2019, Dr. Reddy's Laboratories Ltd.
announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg
Extended-Release Tablets, USP, an over-the-counter (OTC) store-brand equivalent
of Allegra-D 12 HR (USFDA). The following are the ingredients in Dr. Reddy's
OTC Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release
Tablets, USP: For temporary alleviation of symptoms such as runny nose,
sneezing, itchy, watery eyes, and itching of the nose or throat caused by hay
fever or other upper respiratory allergies. Nasal congestion caused by the
common cold, hay fever, or other upper respiratory allergens can be temporarily
relieved with this product. nasal passages to be less swollen. For the most
recent twelve months ending in May 2019, the Allegra-D 12 HR Allergy and
Congestion Extended-Release Tablets brand and generic had US sales of roughly
$44 million MAT. The 20- and 30-count quantities of Dr. Reddy's OTC
Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets,
USP are available.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Product
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Sanofi S.A., Sandoz Inc.
(Novartis International AG, and Dr. Reddy's Laboratories Ltd., among
others.
(Get 15% Discount on Buying this Report)
A
full Report of Fexofenadine Hydrochloride Market is Available @ https://www.omrglobal.com/industry-reports/fexofenadine-hydrochloride-market
Global Fexofenadine Hydrochloride Market Report by
Segment
By Type
• Purity:98%
• Purity:>98%
By Application
• Seasonal Allergic Rhinitis
• Urticaria
Global Fexofenadine Hydrochloride Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment